Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 55.05M | 56.03M | 51.88M | 57.13M | 64.49M | 73.12M |
Gross Profit | 55.05M | 51.11M | 49.62M | 55.28M | 63.01M | 71.79M |
EBITDA | 18.26M | -3.00M | -49.83M | -18.79M | -120.05M | -514.87M |
Net Income | -76.06M | -9.80M | -75.20M | -55.08M | -134.23M | -531.21M |
Balance Sheet | ||||||
Total Assets | 2.63B | 2.68B | 2.75B | 2.84B | 3.19B | 3.33B |
Cash, Cash Equivalents and Short-Term Investments | 252.40M | 331.83M | 202.20M | 169.12M | 158.25M | 85.78M |
Total Debt | 40.35M | 45.54M | 47.68M | 51.00M | 244.83M | 306.74M |
Total Liabilities | 107.69M | 108.09M | 109.31M | 109.58M | 307.95M | 366.59M |
Stockholders Equity | 2.52B | 2.58B | 2.64B | 2.73B | 2.88B | 2.96B |
Cash Flow | ||||||
Free Cash Flow | 11.85M | 14.62M | 21.20M | 17.65M | 32.71M | 27.79M |
Operating Cash Flow | 11.85M | 15.63M | 21.20M | 17.65M | 32.71M | 28.61M |
Investing Cash Flow | -47.54M | 20.80M | 42.97M | 182.66M | 184.34M | -141.93M |
Financing Cash Flow | -9.50M | -8.93M | -10.18M | -204.27M | -80.61M | -142.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $2.65B | 13.61 | 5.58% | 2.92% | -12.74% | -17.17% | |
74 Outperform | HK$269.20B | 15.45 | 2.88% | 4.09% | 20.91% | -29.29% | |
70 Neutral | $146.44B | 8.64 | 4.15% | 4.48% | -10.21% | -40.22% | |
69 Neutral | $79.88B | 21.01 | 2.17% | 1.72% | -30.38% | -43.73% | |
56 Neutral | $13.84B | ― | -10.34% | 9.09% | -56.64% | -3398.20% | |
53 Neutral | $1.18B | 3.34 | -0.11% | 7.12% | -1.52% | -126.00% | |
49 Neutral | HK$499.02M | ― | -2.14% | 0.67% | 1.66% | -51.60% |